Key result
Concomitant left bundle branch area pacing and AVN ablation achieved 92% LBBAP success, 88% AVN ablation success, and 100% same-day discharge with no major complications at 3 months.
Why the study?
Left bundle branch area pacing has demonstrated excellent lead stability, but whether it can allow concomitant AV node ablation and same-day dismissal remained to be evaluated.
Is concomitant left bundle branch area pacing and atrioventricular node ablation with same-day hospital dismissal feasible and safe in patients requiring device implantation?
Observational (n=24)
Is concomitant left bundle branch area pacing and atrioventricular node ablation with same-day hospital dismissal feasible and safe in patients requiring device implantation?
Concomitant left bundle branch area pacing and AVN ablation via left axillary vein access is feasible and safe, allowing for same-day hospital discharge without major short-term complications.
May support same-day discharge after LBBAP with AVN ablation in selected patients; hypothesis-generating and needs prospective confirmation.
BACKGROUND: Left bundle branch area pacing (LBBAP) has rapidly emerged as a promising modality of physiologic pacing and has demonstrated excellent lead stability. In this retrospective study, we evaluate whether this pacing modality can allow concomitant atrioventricular node (AVN) ablation and same-day dismissal. METHODS: Twenty-four consecutive patients (female 63%, male 37%) with an average age of 78 ± 5 years were admitted for pacemaker (75%)/defibrillator (25%) implantations and concomitant AVN ablation. Device implantation with LBBAP was performed first, followed by concomitant AVN ablation through left axillary vein access to allow for quicker post-procedure ambulation. The patients were discharged on the same day after satisfactory post-ambulation device checks. RESULTS: LBBAP was successful in 22 patients (92% in total, 20 patients had an LBBP and two patients had a likely LBBP), followed by AVN ablation from left axillary vein access (21/24, 88%). All patients had successful post-op chest x-rays, post-ambulation device checks, and were discharged on the same day. After a mean follow up of three months, no major complications occurred, such as LBBA lead dislodgement requiring a lead revision. The LBBA lead pacing parameters immediately after implantation vs. three-month follow up were a capture threshold of 0.8 ± 0.3 V@0.4 ms vs. 0.6 ± 0.3 V@0.4 ms, sensing 9.9 ± 3.9 mV vs. 10.4 ± 4.1 mV, and impedance of 710 ± 216 ohm vs. 544 ± 110 ohm. The QRS duration before and after AVN ablation was 117 ± 32 ms vs. 123 ± 14 ms. Mean LVEF before and three months after the implantation was 44 ± 14% vs. 46 ± 12%. CONCLUSION: LBBA pacing not only offers physiologic pacing, but also allows for a concomitant AVN ablation approach from the left axillary vein and safe same-day hospital dismissal.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted an observational in Pacemaker/defibrillator implantation and concomitant AVN ablation (n=24). Concomitant left bundle branch area pacing (LBBAP) and atrioventricular node (AVN) ablation was evaluated on Successful LBBAP and AVN ablation with same-day discharge. Concomitant left bundle branch area pacing and AVN ablation achieved 92% LBBAP success, 88% AVN ablation success, and 100% same-day discharge with no major complications at 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: